Today's 8K. Lookin' good. http://app.quotemedia
Post# of 15624
http://app.quotemedia.com/data/downloadFiling...2017-06-08
Item 8.01. Other Events.
The Registrant has determined to evaluate the potential benefits of cross listing its shares of common stock, currently subject to quotation on the OTCQB: OWCP, for listing on a Canadian stock exchange, such as the Toronto Stock Exchange, among others. We believe that cross listing may improve the Registrant's access to capital and liquidity. To this end, the Registrant has agreed to engage a major national Canadian law firm with specific expertise in venture capital markets to assist us in achieving a listing on a Canadian exchange.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OWC Pharmaceutical Research Corp.
By: /s/ Mordechai Bignitz
Name: Mordechai Bignitz
Title: Chief Executive Officer